Fulcrum Therapeutics Cash Flow Statement (2018-2026) | FULC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-37.99M	-96.47M	-50.95M	-94.00M	-35.44M	-27.08M	-192.46M	-30.52M	-30.65M	-40.26M	-43.11M	-65.24M	40.22M	-25.68M	-71.43M	-29.43M	-41.97M	-64.99M	-84.15M	-49.97M
Depreciation and Depletion (Quarter)	0.70M	0.60M	0.60M	0.50M	0.70M	0.60M	0.59M	0.60M	0.60M	0.50M	0.54M	0.48M	0.40M	0.40M	0.40M	0.40M	0.30M	0.30M	0.40M	0.30M
Share-based Compensation (Quarter)	2.55M	2.66M	3.79M	3.85M	2.88M	3.35M	3.27M	4.25M	3.36M	3.74M	3.45M	3.92M	4.34M	3.82M	2.48M	3.17M	26.10M	22.30M	3.07M	3.86M
Cash from Operations (Quarter)	-17.82M	-22.57M	-21.86M	-22.11M	-27.37M	-27.88M	-19.70M	-24.12M	-20.79M	-22.91M	-23.16M	-25.28M	58.90M	-19.07M	-16.76M	-15.26M	-13.82M	-14.19M	-16.80M	-18.75M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.12M	-0.09M	-0.39M	-0.35M	-0.29M	-0.11M	0.60M	1.37M	1.71M	1.58M	1.33M	1.16M	1.13M	1.15M	0.94M	0.90M	1.08M	0.59M	0.38M	0.77M
Depreciation & Amortization (CF) (Quarter)	0.70M	0.60M	0.60M	0.50M	0.70M	0.60M	0.59M	0.60M	0.60M	0.50M	0.54M	0.48M	0.40M	0.40M	0.40M	0.40M	0.30M	0.30M	0.40M	0.30M
Change in Working Capital
Change in Receivables (Quarter)	-2.00M		2.50M	0.34M	1.81M	0.34M	-3.40M	-0.13M	0.56M	-0.08M	-0.04M	-0.54M	2.33M	1.32M	-1.56M	-1.12M	-0.98M
Change in Account Payables (Quarter)	-0.30M	-0.82M	1.18M	0.51M	-0.04M	-2.55M	0.90M	0.09M	0.16M	-0.29M	-0.82M	1.10M	-0.29M	0.30M	-2.70M	0.34M	0.24M	0.95M	-1.10M	0.86M
Change in Accured Expenses (Quarter)	2.41M	2.35M	-0.80M	-2.40M	5.84M	-4.46M	1.56M	-2.20M	0.77M	-0.31M	0.91M	-3.92M	2.23M	1.30M	-0.64M	-3.34M	0.59M	1.49M	2.29M	-3.77M
Investing Activities
Capital Expenditures (Quarter)	-0.20M	1.14M	0.52M	0.25M	-0.10M	-0.13M	0.01M	0.17M	-0.12M	-0.05M	0.51M	0.03M	-0.01M	0.03M	0.23M			0.15M	0.16M	0.01M
Change in Acquisitions & Divestments (Quarter)	23.00M	23.30M	26.31M	24.89M	42.89M	50.70M	47.04M	32.73M	37.40M	45.07M	43.51M	93.97M	50.73M	42.50M	23.90M	59.62M	90.39M	35.99M	25.25M	27.14M
Cash from Investing Activities (Quarter)	-26.35M	-106.64M	-9.09M	19.66M	31.39M	-2.28M	-36.36M	-93.94M	19.88M	19.02M	18.35M	38.13M	-12.51M	4.35M	2.26M	-0.78M	13.93M	18.61M	-1.05M	-128.21M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	1.26M	4.96M	5.19M	1.67M	1.79M	2.00M	6.50M	2.36M	10.11M	10.11M	9.97M	3.37M	12.55M	4.59M	9.35M	12.01M	12.08M	11.87M	11.65M	13.93M
Net Equity Issued and Repurchased (Quarter)	0.23M	2.38M	0.97M	0.05M	3.11M	0.09M	0.27M	0.35M	0.14M		0.29M	1.65M	0.38M	0.64M	0.08M		0.30M	0.06M	3.80M	0.02M
Misc.
Cash from Financing Activities (Quarter)	0.21M	137.90M	0.89M	0.35M	2.81M	80.95M	0.22M	117.69M	0.14M		0.29M	1.65M	0.38M	0.64M	0.08M		0.30M	0.06M	168.30M	-0.31M
Change in Cash (Quarter)	-43.97M	8.69M	-30.06M	-2.10M	6.84M	50.78M	-55.84M	-0.36M	-0.77M	-3.89M	-4.52M	14.49M	46.77M	-14.09M	-14.42M	-16.03M	0.41M	4.49M	150.46M	-147.27M
Free Cash Flow (Quarter)	-17.62M	-23.71M	-22.38M	-22.35M	-27.27M	-27.75M	-19.70M	-24.29M	-20.66M	-22.86M	-23.67M	-25.31M	58.91M	-19.10M	-16.99M	-15.26M	-13.82M	-14.35M	-16.96M	-18.76M
Net Cash Flow (Quarter)	-43.97M	8.69M	-30.06M	-2.10M	6.84M	50.78M	-55.84M	-0.36M	-0.77M	-3.89M	-4.52M	14.49M	46.77M	-14.09M	-14.42M	-16.03M	0.41M	4.49M	150.46M	-147.27M

Research Tools

Developers

Fulcrum Therapeutics Cash Flow Statement (2018-2026) | FULC

Research Tools

Developers

Fulcrum Therapeutics Cash Flow Statement (2018-2026) | FULC

Create an account

Sign In

Reset Password